| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.036 | 0.5 |